These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 28597200)

  • 1. The Lesion Analysis of Cholinergic Neurons in 5XFAD Mouse Model in the Three-Dimensional Level of Whole Brain.
    Yan H; Pang P; Chen W; Zhu H; Henok K A ; Li H; Wu Z; Ke X; Wu J; Zhang T; Pan K; Pei L; Han Y; Lu Y
    Mol Neurobiol; 2018 May; 55(5):4115-4125. PubMed ID: 28597200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diffusion-weighted magnetic resonance imaging detection of basal forebrain cholinergic degeneration in a mouse model.
    Kerbler GM; Hamlin AS; Pannek K; Kurniawan ND; Keller MD; Rose SE; Coulson EJ
    Neuroimage; 2013 Feb; 66():133-41. PubMed ID: 23128077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myelin changes at the early stage of 5XFAD mice.
    Gu L; Wu D; Tang X; Qi X; Li X; Bai F; Chen X; Ren Q; Zhang Z
    Brain Res Bull; 2018 Mar; 137():285-293. PubMed ID: 29288735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Partial loss in septo-hippocampal cholinergic neurons alters memory-dependent measures of brain connectivity without overt memory deficits.
    Brayda-Bruno L; Mons N; Yee BK; Micheau J; Abrous DN; Nogues X; Marighetto A
    Neurobiol Dis; 2013 Jun; 54():372-81. PubMed ID: 23376311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Butyrylcholinesterase-knockout reduces fibrillar β-amyloid and conserves
    DeBay DR; Reid GA; Macdonald IR; Mawko G; Burrell S; Martin E; Bowen CV; Darvesh S
    Brain Res; 2017 Sep; 1671():102-110. PubMed ID: 28729192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atrophy of the cholinergic Basal forebrain over the adult age range and in early stages of Alzheimer's disease.
    Grothe M; Heinsen H; Teipel SJ
    Biol Psychiatry; 2012 May; 71(9):805-13. PubMed ID: 21816388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cholinergic changes in the APP23 transgenic mouse model of cerebral amyloidosis.
    Boncristiano S; Calhoun ME; Kelly PH; Pfeifer M; Bondolfi L; Stalder M; Phinney AL; Abramowski D; Sturchler-Pierrat C; Enz A; Sommer B; Staufenbiel M; Jucker M
    J Neurosci; 2002 Apr; 22(8):3234-43. PubMed ID: 11943824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A combination Alzheimer's therapy targeting BACE1 and neprilysin in 5XFAD transgenic mice.
    Devi L; Ohno M
    Mol Brain; 2015 Mar; 8():19. PubMed ID: 25884928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intact olfactory memory in the 5xFAD mouse model of Alzheimer's disease from 3 to 15 months of age.
    O'Leary TP; Stover KR; Mantolino HM; Darvesh S; Brown RE
    Behav Brain Res; 2020 Sep; 393():112731. PubMed ID: 32522622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nurr1 (NR4A2) regulates Alzheimer's disease-related pathogenesis and cognitive function in the 5XFAD mouse model.
    Moon M; Jung ES; Jeon SG; Cha MY; Jang Y; Kim W; Lopes C; Mook-Jung I; Kim KS
    Aging Cell; 2019 Feb; 18(1):e12866. PubMed ID: 30515963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PTK2B/Pyk2 overexpression improves a mouse model of Alzheimer's disease.
    Giralt A; de Pins B; Cifuentes-Díaz C; López-Molina L; Farah AT; Tible M; Deramecourt V; Arold ST; Ginés S; Hugon J; Girault JA
    Exp Neurol; 2018 Sep; 307():62-73. PubMed ID: 29803828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of Midbrain Dopamine Neurons and Altered Apomorphine EEG Effects in the 5xFAD Mouse Model of Alzheimer's Disease.
    Vorobyov V; Bakharev B; Medvinskaya N; Nesterova I; Samokhin A; Deev A; Tatarnikova O; Ustyugov AA; Sengpiel F; Bobkova N
    J Alzheimers Dis; 2019; 70(1):241-256. PubMed ID: 31177214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BHBA treatment improves cognitive function by targeting pleiotropic mechanisms in transgenic mouse model of Alzheimer's disease.
    Wu Y; Gong Y; Luan Y; Li Y; Liu J; Yue Z; Yuan B; Sun J; Xie C; Li L; Zhen J; Jin X; Zheng Y; Wang X; Xie L; Wang W
    FASEB J; 2020 Jan; 34(1):1412-1429. PubMed ID: 31914599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impaired hippocampal acetylcholine release parallels spatial memory deficits in Tg2576 mice subjected to basal forebrain cholinergic degeneration.
    Laursen B; Mørk A; Plath N; Kristiansen U; Bastlund JF
    Brain Res; 2014 Jan; 1543():253-62. PubMed ID: 24231553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neprilysin deficiency alters the neuropathological and behavioral phenotype in the 5XFAD mouse model of Alzheimer's disease.
    Hüttenrauch M; Baches S; Gerth J; Bayer TA; Weggen S; Wirths O
    J Alzheimers Dis; 2015; 44(4):1291-302. PubMed ID: 25408216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deep Brain Magnetic Stimulation Promotes Neurogenesis and Restores Cholinergic Activity in a Transgenic Mouse Model of Alzheimer's Disease.
    Zhen J; Qian Y; Fu J; Su R; An H; Wang W; Zheng Y; Wang X
    Front Neural Circuits; 2017; 11():48. PubMed ID: 28713248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Normalizing the gene dosage of Dyrk1A in a mouse model of Down syndrome rescues several Alzheimer's disease phenotypes.
    García-Cerro S; Rueda N; Vidal V; Lantigua S; Martínez-Cué C
    Neurobiol Dis; 2017 Oct; 106():76-88. PubMed ID: 28647555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene Dosage Dependent Aggravation of the Neurological Phenotype in the 5XFAD Mouse Model of Alzheimer's Disease.
    Richard BC; Kurdakova A; Baches S; Bayer TA; Weggen S; Wirths O
    J Alzheimers Dis; 2015; 45(4):1223-36. PubMed ID: 25697701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cholinergic degeneration is associated with increased plaque deposition and cognitive impairment in APPswe/PS1dE9 mice.
    Laursen B; Mørk A; Plath N; Kristiansen U; Bastlund JF
    Behav Brain Res; 2013 Mar; 240():146-52. PubMed ID: 23178660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Motor deficits, neuron loss, and reduced anxiety coinciding with axonal degeneration and intraneuronal Aβ aggregation in the 5XFAD mouse model of Alzheimer's disease.
    Jawhar S; Trawicka A; Jenneckens C; Bayer TA; Wirths O
    Neurobiol Aging; 2012 Jan; 33(1):196.e29-40. PubMed ID: 20619937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.